Role of Lacrimal Canalicular Trephination and Mini-Monoka Stent in the Management of Idiopathic Distal Canalicular Obstructions

Abstract

Lacrimal canalicular trephination with Mini-Monoka stent insertion is an easy, monocanalicular and lesser invasive technique, which has never been reported earlier in literature. We conclude that this repeatable procedure has good anatomical and functional success rates with minimal complications as compared with the other available treatment modalities for lacrimal canalicular obstructions.

Outcomes of canalicular trephination versus canaliculodacryocystorhinostomy in common canalicular blocks

“…Outcomes of our study correlated well with the previous study by Zadeng et al who described canalicular trephination in 24 patients with common and distal canalicular blocks and reported an anatomical success of 91.67% and 83.33% of patients with absent epiphora indicating functional success at a minimum of 8-month follow-up. [ 31 ]…”

Long-term outcomes of lacrimal canalicular trephination with viscoelastic-assisted monocanalicular stenting for canalicular obstructions

“…0 for locating the level of LCO. The technique of measuring or finding the level of LCO has also been described by us [1,8].…”

“…Historically, Sisler and Allarakhia (1990) invented a lacrimal transcanalicular mini-trephine for treating LCO as an office-based procedure [6,7]. Its simple design and easy to use made Sisler's lacrimal trephine one of the most favorite instruments in the armamentarium of a dacryologist [1,5,8]. This trephine has attracted worldwide attention and has been used with success rates ranging from 52-92% [6][7][8][9][10][11][12][13][14][15].…”

“…Its simple design and easy to use made Sisler's lacrimal trephine one of the most favorite instruments in the armamentarium of a dacryologist [1,5,8]. This trephine has attracted worldwide attention and has been used with success rates ranging from 52-92% [6][7][8][9][10][11][12][13][14][15]. This technique was described in one of the pioneering articles in 2014 in patients of idiopathic lower LCO with a satisfactory success rate (83.3%) over 8.6 months [8].…”

“…This trephine has attracted worldwide attention and has been used with success rates ranging from 52-92% [6][7][8][9][10][11][12][13][14][15]. This technique was described in one of the pioneering articles in 2014 in patients of idiopathic lower LCO with a satisfactory success rate (83.3%) over 8.6 months [8].…”